Cite

HARVARD Citation

    Furst, D. et al. (2013). FRI0223 Long-term targeted safety event rates in ra patients following initiation of rituximab: interim analysis from sunstone registry. Annals of the rheumatic diseases. pp. A448-A449. [Online]. 
  
Back to record